GE HealthCare Appoints William Grogan as Chief Financial Officer

What Happened
GE HealthCare Technologies Inc. announced on August 18, 2026 (via Form 8-K) that its Board appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026. Interim CFO George A. Newcomb will stop serving in the interim CFO role on that date and will continue as Controller and Chief Accounting Officer. Mr. Grogan joins from Xylem Inc., where he has been Executive VP & CFO since October 2023, and previously served as CFO of IDEX Corporation.

Key Details

• Annual base salary: $900,000; target annual bonus: 100% of base salary.
• Annual long-term incentive (LTI) target: $3,300,000 (grant date value).
• One-time sign-on equity award: $4,000,000 in RSUs granted 9/14/2026, vesting 50% on the 1st anniversary and 50% on the 2nd anniversary (with pro-rata vesting on certain terminations).
• Cash sign-on: $550,000 to compensate for forfeited 2026 bonus from prior employer; subject to repayment if Mr. Grogan resigns within two years or is terminated for cause.
• 2026 annual LTI award (granted 9/14/2026) valued at $3,300,000: 50% performance stock units (performance period Jan 1, 2026–Dec 31, 2028; payout certified in Q1 2029), 25% RSUs and 25% stock options vesting ~33% each Sept 2 of 2027–2029.
• Employment conditioned on signing GE HealthCare Protective Covenants and Employee Innovation & Proprietary Information agreements. No related-party transactions or family ties disclosed.

Why It Matters
A permanent CFO appointment clarifies GE HealthCare’s finance leadership and succession after an interim period, which investors monitor for financial strategy and reporting continuity. The compensation package (base, bonus target, significant equity awards and sign-on payments) aligns Mr. Grogan’s pay with multi-year performance and retention, and the LTI structure ties a substantial portion of pay to company performance through 2028–2029 vesting schedules.